FDA Inspection 1169367 — Lear Corporation (AccuMed)
The FDA completed an inspection of Lear Corporation (AccuMed) on Apr 25, 2022 in Pine Grove, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 25, 2022
- Fiscal Year
- 2022
- Product Type
- Devices
- Project Area
- Compliance: Devices
- Location
- Pine Grove, PA (United States)